← Back to Patent Explorer
US5541287A Expired / Lapsed US ⏱️ 0.0 years remaining

Pretargeting methods and compounds

Assignee: Aletheon Pharmaceuticals Inc
•
Filing: 1994-11-22
•
Granted: 1996-07-30
•
Expires: 2014-11-22
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Methods, compounds, compositions and kits that relate to pretargeted delivery of diagnostic and therapeutic agents are disclosed. In particular, methods for radiometal labeling of biotin, as well as related compounds, are described. Articles of manufacture useful in pretargeting methods are also discussed.

Inventors

  • 👤 Eric K. Yau
  • 👤 Louis J. Theodore
  • 👤 Linda M. Gustavson

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 19:26
CPC Classifications
B; B82; B82Y; B82Y5/00; A; A61; A61K; A61K47/00; A61K47/50; A61K47/51; A61K47/68; A61K47/6891; A61K47/6893; A61K47/54; A61K47/555; A61K47/557; A61K47/62; A61K47/66; A61K47/665; A61K47/6835; A61K47/6887; A61K47/6897; A61K47/6898; A61K51/00; A61K51/02; A61K51/04; A61K51/0497; A61K51/12; A61K51/1268; C; C07; C07K; C07K1/00; C07K1/107; C07K1/1072; C07K1/1077; C07K5/00; C07K5/04; C07K5/12; C07K5/126; A61K2121/00; A61K2123/00

Claims Analysis

Total Claims: 14
Claim 1
Independent Claim 73 words
A method of producing nitro-benzyl-DOTA via the select N-alkylation of a compound having a trifluoroacetamide group with an iodoacetyl derivative in the presence of base comprising: treating an acyclic tripeptide having an N-terminal amino group and a C-terminal carboxyl group with an activating agent such that said carboxyl group of said acyclic tripeptide becomes susceptible to closure by said amino group; and allowing said acyclic tripeptide to cyclize to form a cyclic tripeptide.
Claim 2
Independent Claim 73 words
A method of producing nitro-benzyl-DOTA via the select N-alkylation of a compound having a trifluoroacetamide group with an iodoacetyl derivative in the presence of base comprising: treating an acyclic tripeptide having an N-terminal amino group and a C-terminal carboxyl group with an activating agent such that said carboxyl group of said acyclic tripeptide becomes susceptible to closure by said amino group; and allowing said acyclic tripeptide to cyclize to form a cyclic tripeptide.
Claim 3
Dependent Claim 11 words
The method of claim 1, wherein said trifluoroacetamide group is N-BOC-glycyltrifluoroacetylethylenediamine.
Claim 4
Dependent Claim 13 words
The method of claim 1, wherein said iodoacetyl derivative is iodoacetyl-p-nitrophenylalanine t-butyl ester.
Claim 5
Dependent Claim 11 words
The method of claim 1, wherein said acyclic tripeptide is glycyl-N-ethylenediamino-N'-tri-fluoroacetyl-N'-methylcarbonyl-p-nitrophenylalanine.
Claim 6
Dependent Claim 17 words
The method of claim 1, wherein said cyclic tripeptide is 2-(p-nitrobenzyl)-3, 6, 9, 12-trioxy-10-trifluoroacetyl-1, 4, 7, 10-tetraazacyclododecane.
Claim 7
Dependent Claim 19 words
The method of claim 1, wherein cyclization is effected with benzotriazolyloxy-tris(dimethylamino)phosphoride hexa-fluoro-phosphate (BOP) in dimethylformamide (DMF) and diisopropylethylamine (DIEA).
Claim 8
Independent Claim 113 words
A method for the synthesis of 2-(p-nitrophenyl)-1,4,7,10-tetraazacyclododecane which comprises: (i) reacting ethylenediamine with N-BOC-p-nitrophenylglycinate to produce ##STR49## (ii) reacting the product of (i) with CF 3 CO 3 Et and methanol to produce ##STR50## (iii) reacting the product of (ii) with ##STR51## in the presence of NaH and THF to produce ##STR52## (iv) reacting the product of (iii) with THF and CH 2 Cl 2 to produce ##STR53## (v) reacting the product of (iv) with benzotriazolyl-oxy-tris(dimethylamino)phosphonium hexafluorophosphate (BOP), DMF and DIEA to produce ##STR54## (vi) reacting the product of (v) with NH 4 OH and methanol to produce ##STR55## (vii) reacting the product of (vi) with BH 3 and THF to produce 2-(p-nitrophenyl)-1,4,7,10-tetraazacyclododecane.
Claim 9
Independent Claim 113 words
A method for the synthesis of 2-(p-nitrophenyl)-1,4,7,10-tetraazacyclododecane which comprises: (i) reacting ethylenediamine with N-BOC-p-nitrophenylglycinate to produce ##STR49## (ii) reacting the product of (i) with CF 3 CO 3 Et and methanol to produce ##STR50## (iii) reacting the product of (ii) with ##STR51## in the presence of NaH and THF to produce ##STR52## (iv) reacting the product of (iii) with THF and CH 2 Cl 2 to produce ##STR53## (v) reacting the product of (iv) with benzotriazolyl-oxy-tris(dimethylamino)phosphonium hexafluorophosphate (BOP), DMF and DIEA to produce ##STR54## (vi) reacting the product of (v) with NH 4 OH and methanol to produce ##STR55## (vii) reacting the product of (vi) with BH 3 and THF to produce 2-(p-nitrophenyl)-1,4,7,10-tetraazacyclododecane.
Claim 10
Dependent Claim 21 words
The method of claim 7, wherein said α-(p-nitrophenyl)-1,4,7,10-tetraazacyclododecane obtained in step (vii) is converted to 2-(p-nitrobenzyl)-DOTA by reaction with bromoacetic acid.
Claim 11
Independent Claim 97 words
A method of producing the product ##STR56## comprising the following steps: treating an acyclic tripeptide having an N-terminal amino group and a C-terminal carboxyl group with an activating agent under conditions wherein the carboxyl group of said acyclic tripeptide becomes susceptible to closure by said amino group, and wherein the acyclic tripeptide is glycyl-N-ethylenediamino-N'-trifiuoroacetyl-N'-methylcarbonyl-p-nitrophenylalanine; and wherein cyclization is effected with benzyltriazolyloxy-tris(dimaethylamino)phosphoride hexafiuoro-phosphate (BOP) in dimethylformamide (DMF) and diisopropylethylamine (DIEA) to produce a cyclic peptide compound having the following structure: ##STR57## reacting the previous cyclic compotmd in the presence of ammonium hydroxide and methanol to produce said product.
Claim 12
Independent Claim 97 words
A method of producing the product ##STR56## comprising the following steps: treating an acyclic tripeptide having an N-terminal amino group and a C-terminal carboxyl group with an activating agent under conditions wherein the carboxyl group of said acyclic tripeptide becomes susceptible to closure by said amino group, and wherein the acyclic tripeptide is glycyl-N-ethylenediamino-N'-trifiuoroacetyl-N'-methylcarbonyl-p-nitrophenylalanine; and wherein cyclization is effected with benzyltriazolyloxy-tris(dimaethylamino)phosphoride hexafiuoro-phosphate (BOP) in dimethylformamide (DMF) and diisopropylethylamine (DIEA) to produce a cyclic peptide compound having the following structure: ##STR57## reacting the previous cyclic compotmd in the presence of ammonium hydroxide and methanol to produce said product.
Claim 13
Independent Claim 113 words
A method of producing the following product: ##STR58## comprising the following steps: treating an acyclic peptide having an N-tenninal amino group and a C-terminal carboxyl group with an activating agent under conditions wherein the carboxyl group of said acyclic peptide becomes susceptible to closure by said amino group, and wherein the acyclic tripeptide is glycyl-N-ethylenediamino-N'-trifluoroacetyl-N'-methylcarbonyl-p-nitrophenylalanine; and cyclization is effected with benzotriazolyloxy-tris(dimethylamino)phosphoride hexafluoro-phosphate (BOP) in dimethylformamide (DMF) and diisopropylethylamine (DIEA) to produce a cyclic peptide compound having the following structure: ##STR59## reacting the previous cyclic coinpound in the presence of ammonium hydroxide and methanol to produce the following compound: ##STR60## and reacting the previous compound with BF 3 and THF to produce said product.
Claim 14
Independent Claim 113 words
A method of producing the following product: ##STR58## comprising the following steps: treating an acyclic peptide having an N-tenninal amino group and a C-terminal carboxyl group with an activating agent under conditions wherein the carboxyl group of said acyclic peptide becomes susceptible to closure by said amino group, and wherein the acyclic tripeptide is glycyl-N-ethylenediamino-N'-trifluoroacetyl-N'-methylcarbonyl-p-nitrophenylalanine; and cyclization is effected with benzotriazolyloxy-tris(dimethylamino)phosphoride hexafluoro-phosphate (BOP) in dimethylformamide (DMF) and diisopropylethylamine (DIEA) to produce a cyclic peptide compound having the following structure: ##STR59## reacting the previous cyclic coinpound in the presence of ammonium hydroxide and methanol to produce the following compound: ##STR60## and reacting the previous compound with BF 3 and THF to produce said product.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1999-07-30 2000-01-29 2000-07-30 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2003-07-30 2004-01-29 2004-07-30 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2007-07-30 2008-01-29 2008-07-30 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag